content

CAGR of 11% Projected In Bioavailability Enhancement Market

Since more biopharmaceutics classification system- BCS II as well as BCS IV molecules are being evaluated in the early stages of development, one of...

Wales Life Sciences Spectrum Stamping Its Peerless Authority

Office for Life Sciences- OLS numbers, which were released on December 1, 2022, and cover data till the end of the financial year in...

Duchenne Muscular Dystrophy And Cancer Have A Genetic Link

Scientists from the University of Portsmouth have settled on a novel genetic link between Duchenne muscular dystrophy and cancer. Duchenne muscular dystrophy, which happens...

First CAR-T Cell For Muscle Inflammation Cure Rolled Out

One of the university hospitals in Germany was the first in the world to effectively treat a patient with a severe case of muscular...

Chinese Drug Development Fund Gets $500mn Boost In Hong Kong

The Hong Kong government announced plans to add $500 million to the Chinese Medicine Development Fund beginning with this fiscal year during a budget...

Bend Bioscience Opens New Drug Delivery Innovation Lab

Bend Bioscience announced the opening of an R&D and Innovation lab in Bend, Oregon. The 4,500 square-foot facility includes lab and office space as...

Chiesi Global Rare Diseases Announces FDA Approval of Lamzede for Alpha-Mannosidosis

Chiesi Global Rare Diseases, a business unit of Chiesi Farmaceutici S.p.A., an international research-focused healthcare Group (Chiesi Group), announced that the U.S. FDA has...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read